Haleon plc ADR (NYSE: HLN) on Monday, soared 3.93% from the previous trading day, before settling in for the closing price of $10.18. Within the past 52 weeks, HLN’s price has moved between $7.89 and $10.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.97%. The company achieved an average annual earnings per share of 6.61%. With a float of $4.20 billion, this company’s outstanding shares have now reached $4.53 billion.
In terms of profitability, gross margin is 61.06%, operating margin of 18.99%, and the pretax margin is 15.96%.
Haleon plc ADR (HLN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Haleon plc ADR is 7.31%, while institutional ownership is 11.86%.
Haleon plc ADR (HLN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.61% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.50% during the next five years compared to 17.60% growth over the previous five years of trading.
Haleon plc ADR (NYSE: HLN) Trading Performance Indicators
Haleon plc ADR (HLN) is currently performing well based on its current performance indicators. A quick ratio of 0.78 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.34. Likewise, its price to free cash flow for the trailing twelve months is 21.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.40, a number that is poised to hit 0.13 in the next quarter and is forecasted to reach 0.53 in one year’s time.
Technical Analysis of Haleon plc ADR (HLN)
Looking closely at Haleon plc ADR (NYSE: HLN), its last 5-days average volume was 10.21 million, which is a drop from its year-to-date volume of 10.38 million. As of the previous 9 days, the stock’s Stochastic %D was 67.40%. Additionally, its Average True Range was 0.22.
During the past 100 days, Haleon plc ADR’s (HLN) raw stochastic average was set at 96.63%, which indicates a significant increase from 93.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.66% in the past 14 days, which was higher than the 20.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.63, while its 200-day Moving Average is $9.50. However, in the short run, Haleon plc ADR’s stock first resistance to watch stands at $10.66. Second resistance stands at $10.74. The third major resistance level sits at $10.83. If the price goes on to break the first support level at $10.48, it is likely to go to the next support level at $10.39. Now, if the price goes above the second support level, the third support stands at $10.31.
Haleon plc ADR (NYSE: HLN) Key Stats
Market capitalization of the company is 47.90 billion based on 4,527,073K outstanding shares. Right now, sales total 14,059 M and income totals 1,305 M. The company made 3,616 M in profit during its latest quarter, and 630,790 K in sales during its previous quarter.
